Frontlight ResearchEarly access
Trial site
Kardio Brynów Sp. z o.o.
- 8running trials
- 7closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Hypertrophic cardiomyopathy7 trials
- Heart failure4 trials
- Atrial fibrillation3 trials
- Aortic stenosis1 trial
- Stroke1 trial
- Phase
- Phase 36 trials
- Phase 25 trials
- Phase 2/33 trials
- Phase 41 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- Myokardia Inc.3 trials
- Cytokinetics2 trials
- Anthos Therapeutics, Inc.1 trial
- Bristol-Myers Squibb1 trial
- Imbria Pharmaceuticals Inc.1 trial
- and 7 more
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hypertrophic cardiomyopathy2 recruiting
- Aortic stenosis1 recruiting
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy
Active, not recruiting
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026